Evidence map›Paper›PMID 41951628›Full record

ArticleNature communications2026

Proviral NUP153 binding to viral proteins and RNA regulates structural-nonstructural protein ratios in orthoflavivirus infection.

Marie B A Peters, Richard Lindqvist, Eszter Kassa, Wai-Lok Yau, Pallabi Sengupta, Isabell Niedermoser, Gisa Gerold, Nasim Sabouri, Ylva Ivarsson, Richard Lundmark and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marie B A PetersDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.ORCID 0000-0001-8994-0864
Richard LindqvistDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.
Eszter KassaDepartment of Chemistry for Life Sciences, Uppsala University, Uppsala, Sweden.
Wai-Lok YauLaboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå, Sweden.
Pallabi SenguptaDepartment of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.ORCID 0000-0002-1413-9412
Isabell NiedermoserInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-5301-3361
Gisa GeroldInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-1326-5038
Nasim SabouriDepartment of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.ORCID 0000-0002-4541-7702
Ylva IvarssonDepartment of Chemistry for Life Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-7081-3846
Richard LundmarkLaboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå, Sweden.ORCID 0000-0001-9104-724X
Anna K ÖverbyDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden. anna.overby@umu.se.ORCID 0000-0001-6553-0940

Funding

Cancerfonden (Swedish Cancer Society) 22 2380 PjDeutsche Forschungsgemeinschaft (German Research Foundation) INST 193/90-1 FUGG; project-ID: 497694394Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) KAW2021-0173Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) KAW2024-0039Stiftelsen för Strategisk Forskning (Swedish Foundation for Strategic Research) SB16-0039Vetenskapsrådet (Swedish Research Council) 2018-05851Vetenskapsrådet (Swedish Research Council) 2020-03380Vetenskapsrådet (Swedish Research Council) 2020-06224Vetenskapsrådet (Swedish Research Council) 2021-02468Vetenskapsrådet (Swedish Research Council) 2024-00390
6 · The paper itself

Abstract

Orthoflaviviruses are RNA viruses that cause serious diseases in humans, with currently no antivirals available. Targeting host factors is emerging as an attractive antiviral approach. However, as a first step, there is a need to understand which host proteins are hijacked and for what purpose. Here, using a combination of fluorescence microscopy, knock-down, crosslinking immunoprecipitation sequencing, mass spectrometry, and in vitro and biophysical assays, we identify nucleoporin-153 (NUP153) as a proviral factor during orthoflavivirus infection. We show that NUP153 is recruited to the virus amplification site on the endoplasmic reticulum to impact the structural to nonstructural viral protein ratios. We find that NUP153 interacts with both the viral proteins NS3 and NS5, and a highly conserved G-rich motif on the viral RNA. These interactions specifically promote the production of viral structural proteins, leading to an efficient virion assembly, virus release and spread to new cells. We propose that NUP153 acts as a key regulator in viral protein ratios, a mechanism that appears conserved among orthoflaviviruses.

Indexed as

Nuclear Pore Complex ProteinsRNA, ViralViral Nonstructural ProteinsViral ProteinsAnimalsEndoplasmic ReticulumHEK293 CellsHost-Pathogen InteractionsHumansProtein BindingVirus AssemblyNuclear Pore Complex ProteinsNUP153 protein, humanRNA, ViralViral Nonstructural ProteinsViral Proteins

Identifiers

PMID41951628
PMCPMC13068965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.